[vc_row][vc_column width=”1/2″][vc_single_image image=”11336″ alignment=”center”][/vc_column][vc_column width=”1/2″][vc_single_image image=”11337″ alignment=”center”][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row css=”.vc_custom_1594763160491{margin-bottom: 100px !important;}”][vc_column][vc_empty_space][vc_column_text]In April’s CAC2 All-Member Webinar, Dr. Brian D. Crompton (pediatric oncologist at Dana Farber/Boston Children’s Hospital) and CAC2 Member Greg Harper (Living LFS) presented about the possibilities with emerging technology identifying circulating cancer cells with liquid biopsies, using Li-Fraumeni Syndrome as a case study.
The presentation below described the investigation into a liquid biopsy for Li-Fraumeni Syndrome patients and the EDISYN consortium and how nonprofits partnering with medical research centers to help empower patients and families.[/vc_column_text][vc_video link=”https://youtu.be/12cIEnGwFGg” align=”center”][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
